Japan
-
China remains one of the fastest growing pharmaceutical markets in the world
China and Japan will be the largest and second largest pharmaceutical markets in the Asia Pacific region in 2016.
Japan | 27 April 2012
-
Pharmaceutical companies from Japan, India and China are amongst Asia Pacific’s most innovative
Pharmaceutical companies from Japan, India and China were among Asia Pacific’s leading innovators last year according to one of two reports released by Thomson Reuters, which provide new insights into global patent and trademark trends throughout 2011.
Japan | 28 March 2012
-
Novartis receives approval in Japan for two innovative therapies
Approvals demonstrate ongoing Novartis commitment to bringing innovative treatments to patients in Japan.
Japan | 27 September 2011
-
AstraZeneca announces first approval of FASLODEX in Japan
In Japan, it is estimated that annually 10,000 women with metastatic breast cancer will have their cancer recurring or progressing post endocrine therapy.
Japan | 26 September 2011
-
Launch of Lexapro commenced in Japan
H Lundbeck A/S announced that its partners Mochida Pharmaceutical Co Ltd and Mitsubishi Tanabe Pharma Corporation (MTPC) have launched Lexapro 10mg (escitalopram) in Japan, for which Mochida obtained the marketing approval following the NHI (National…
Japan | 22 August 2011
-
Leading Japanese pharmaceutical scientists advance drug discovery and development
Research aims to deliver new paths to more effective drugs based on advancements in protein analysis.
Japan | 08 August 2011
-
FUJIFILM, Dr Reddy's establish exclusive joint venture on generic drugs in Japan
FUJIFILM Corporation President and CEO, Shigetaka Komori and Dr Reddy's Laboratories Ltd Vice-Chairman and CEO, G V Prasad signed a memorandum of understanding to enter into an exclusive partnership in the generic drugs business for the Japanese mark…
Japan | 29 July 2011
-
Japan and China dominate Asian active pharmaceutical ingredients market
The market for active pharmaceutical ingredients (APIs) is highest in the US, followed by Europe and Asia Pacific – the geographic market reporting fastest growth. According to a new report on companiesandmarkets.com, revenue growth in the Asia-Pac…
Japan | 14 July 2011
-
Gyros and GE Healthcare Life Sciences sign distribution agreement for Japan
Brings the Gyros nanoliter-scale immunoassay platform to biopharmaceutical and vaccine manufacturers in Japan.
Japan | 12 July 2011
-
Pfizer announces phase 3 study results of patients with Fibromyalgia in Japan
Pfizer Japan announced the top-line results for Lyrica (pregabalin) Study A0081208 – Randomized, Double-Blind, Multicenter, Placebo-Controlled Study to Evaluate Efficacy and Safety of Pregabalin (CI-1008) in the Treatment of Fibromyalgia. According…
Japan | 07 July 2011
